Results 201 to 210 of about 6,710,280 (212)
Some of the next articles are maybe not open access.
Genetic Basis of Anti-Tuberculosis Drug-Induced Liver Injury (AT-DILI)
Anti-tuberculosis drug-induced liver injury (AT-DILI) is a severe adverse drug reaction associated with using anti-tuberculosis medications. Isoniazid, rifampicin, and pyrazinamide are potentially hepatotoxic drugs used in TB treatment. The rate of AT-DILI ranges from 2 to 28%, and this is also attributed to genetic factors.Heikrujam Nilkanta Meitei +3 more
openaire +1 more source
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Gastroenterology, 2015Herbert L Bonkovsky +2 more
exaly
A Case Report of Rifampin Alone Drug Induced Liver Injury (DILI)
American Journal of Gastroenterology, 2018Ashina D. Singh +2 more
openaire +1 more source
Analysis of IL-10, IL-4 and TNF-α Polymorphisms in Drug-Induced Liver Injury (DILI) and Its Outcome
Journal of Hepatology, 2008Manuel Romero-Gomez +2 more
exaly
Doxycycline: Rare but Real Cause of DILI (Drug-Induced Liver Injury)
International Journal of Pharmaceutical Research, 2020openaire +1 more source
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
Clinical Gastroenterology and Hepatology, 2018Encarnación Blanco +2 more
exaly
The Challenge of Drug-Induced Liver Injury (DILI) / Challenges and Management of Liver Cirrhosis
2015openaire +1 more source